CD8A and malaria: In this regard, we have recently demonstrated that when a peptide-based PD1 antagonist is prophylactically-combined with an adenovirus-based or irradiated sporozoite-based malaria vaccination, antigen-specific CD8 T cell expansion is enhanced (48).